FOSTAMATINIB (has an active metabolite) | FOSTAMATINIB | ATC B02BX09
ANTINEOPLASTIC TYROSINE KINASE SYK INHIBITOR INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA METABOLIZED IN THE GUT BY ALKALINE PHOSPHATASE | ORAL | SOLUBILITY SLIGHTLY SOLUBLE IN WATER | PHOSPHATASE PDB 4O75 (CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH FOSTAMATINIB) LIGAND CODE = 2RC (link to the list of PDB complexes) Download experimental 3D coordinates of 2RC with added hydrogens | Tyrosine-protein kinase SYK UNIPROT P43405 SYK more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |